Rogue Antibodies Involved In Nearly One-fifth Of COVID Deaths
Self-targeting antibodies attack part of the immune system that plays a key role in fighting infection -- Read more on ScientificAmerican.com
Self-targeting antibodies attack part of the immune system that plays a key role in fighting infection -- Read more on ScientificAmerican.com
Rather than crystallizing all at once, kidney stones dissolve and re-form over and over -- Read more on ScientificAmerican.com
A generation of new tests could lessen overuse of antibiotics -- Read more on ScientificAmerican.com
The assay could also help evaluate organ transplants and fetal genetic disorders -- Read more on ScientificAmerican.com
Shorter courses cause fewer side effects and breed fewer antibiotic-resistant “superbugs” -- Read more on ScientificAmerican.com
The U.S.’s top infectious disease specialist describes a new Biden administration program to develop and test antivirals—and what he’s most worried about as the nation reopens -- Read more on ScientificAmerican.com
A genomic revolution is poised to cure sickle cell and other genetic diseases -- Read more on ScientificAmerican.com
Developing pills that block the novel coronavirus has been challenging. A new Biden administration program aims to boost the effort -- Read more on ScientificAmerican.com
Studies suggest mixing vaccines provokes potent immune responses, but scientists want answers on real-world efficacy and rare side effects -- Read more on ScientificAmerican.com
Scientists are searching for explanations to disappointing final-stage trial results. These insights could help guide the future development of mRNA vaccines -- Read more on ScientificAmerican.com
This revolutionary gene-editing system has taken science by storm. -- Read more on ScientificAmerican.com
Fee-for-service models, as in the U.S., and single-payer models like the U.K.’s and Canada’s both have significant flaws—but Singapore may have found a workable compromise -- Read more on ScientificAmerican.com
Many scientists say there is not enough evidence that Biogen’s aducanumab is an effective therapy for the disease -- Read more on ScientificAmerican.com
It’s one of the most challenging organs to re-create -- Read more on ScientificAmerican.com
A pediatric infectious disease expert answers questions about whether the vaccine is safe, and why children need it -- Read more on ScientificAmerican.com
Preliminary results from a trial of more than 600 people are the first to show the benefits of combining different vaccines -- Read more on ScientificAmerican.com